gene editing

Cell & Gene Therapy 2018

https://pharmaphorum.com/events/cell-gene-therapy-2018/

Kite and Sangamo come together in $3bn cancer gene editing alliance

https://pharmaphorum.com/views-analysis-oncology/kite-sangamo-come-together-3bn-cancer-gene-editing-alliance/

No safety concerns so far in Sangamo’s groundbreaking gene-editing trial

https://pharmaphorum.com/news/no-safety-concerns-far-sangamos-groundbreaking-gene-editing-trial/

Sangamo edits living patient’s DNA for first time

https://pharmaphorum.com/news/us-doctors-gene-editing/

CRISPR & Precision Gene Editing Congress – Berlin 2017

https://pharmaphorum.com/events/crispr-precision-gene-editing-congress-berlin-2017/

Dr. Dana Carroll to deliver keynote on challenges in Programmable Genome Editing.

https://pharmaphorum.com/partner-content/dr-dana-carroll-deliver-keynote-challenges-programmable-genome-editing/

CRISPR Therapeutics plans Nasdaq launch

https://pharmaphorum.com/news/crispr-therapeutics-plans-nasdaq-launch/

Fulcrum Therapeutics promises new drugs for rare disorders

https://pharmaphorum.com/news/fulcrum-therapeutics-promises-new-drugs-rare-disorders/

Caribou gains $30m funding for CRISPR-Cas platform

https://pharmaphorum.com/news/caribou-biosciences-nabs-30m-funding-for-crispr-cas-platform/

1 2 3

Close in 10 seconds

Pharmaphorum.com

Search